Hrt Financial »

Apimeds Pharmaceuticals Us I shares owned by Hrt Financial

Quarter-by-quarter ownership of Apimeds Pharmaceuticals Us I (APUS) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Apimeds Pharmaceuticals Us I

Tip: Access up to 7 years of quarterly data

All positions including Apimeds Pharmaceuticals Us I held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apimeds Pharmaceuticals Us I by Hrt Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $24k 14k 1.77

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Apple Put
Ishares Tr Russell 2000 Etf (IWM)
Nvidia Corporation Put
Microsoft Corporation (MSFT)
Microsoft Corp Put
Johnson & Johnson (JNJ)
Amphenol Corp Cl A (APH)
Applovin Corp Call
Grab Holdings Class A Ord (GRAB)
Apple Call
Tesla Motors (TSLA)

View all positions for Hrt Financial

Top funds holding Apimeds Pharmaceuticals Us I

Hemenway Trust Company
Vanguard Group
Geode Capital Management
Renaissance Technologies
XTX Topco
Hrt Financial
Jpmorgan Chase & Co

View all funds holding Apimeds Pharmaceuticals Us I